🇺🇸 FDA
Patent

US 6699674

Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines

expired A61KA61K39/00

Quick answer

US patent 6699674 (Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines) held by United States of America as represented by the Secretary of the Air Force expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K39/00